US TNBC is estimated to be ~40,000 per year. RP previously said that over 95% TNBC over-express CCR5, but with the new criteria including the macrophages CCR5, it may be 100%? This 40,000 is based on an estimated 10-20% of breast cancer is TNBC. Most cancer site I’ve seen estimate US breast cancer to be ~268,000 for 2019.....so 15% is right at 40,000 TNBC. I think Guru provided some links, but they have been posted on IH previously also.....I posted a cancer potential several months ago that looked at the US cancer market potential. Feel much more realistic now that the early human results are unbelievable. Crunch some numbers and you won’t think ohm, myself and a few others are completely crazy.
(4)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.